<DOC>
	<DOCNO>NCT00567060</DOCNO>
	<brief_summary>The purpose study explore document way relative potential efficacy piracetam 9600 4800 mg daily .</brief_summary>
	<brief_title>Efficacy Safety Piracetam Taken 12 Months Subjects Suffering From Mild Cognitive Impairment ( MCI )</brief_title>
	<detailed_description />
	<mesh_term>Cognition Disorders</mesh_term>
	<mesh_term>Mild Cognitive Impairment</mesh_term>
	<mesh_term>Memory Disorders</mesh_term>
	<criteria>male/female 50 89 year ( inclusive ) decline cognitive function least 3 month duration interfere complex activity daily live normal basic activity daily independent live Clinical Dementia Rating scale score equal 0.5 score least one point low possible score 7 8 test cognitive battery Selection Visit Baseline Visit general anesthetic within 3 month selection visit history severe allergic drug reaction ( ) history drug alcohol dependence ( DSM IV define ) within last 12 month drug prescribe activate cerebral metabolism , take within 1 week screen or/and concomitantly concomitant intake anticoagulent medication concomitant intake intake within 1 week screen drug might affect cognitive function central nervous system history dementia , psychiatric neurological disorder , mental retardation , learn disability stroke current depression impair renal function , thyroid function neurological degeneration gastrointestinal dysfunction might interfere absorption elimination study drug insulindependant diabetes mellitus bleed disorder disturbance hemostatic function .</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>89 Years</maximum_age>
	<verification_date>September 2009</verification_date>
	<keyword>Piracetam</keyword>
	<keyword>Nootropil</keyword>
</DOC>